599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)

Javier Carrasco, G. Beniuga, Anne Jouret‐Mourin, Paméla Baldin, Isabelle Sinapi, Darrell R. Schroeder, Astrid De Cuyper, Francesco Sclafani, Alain Hendlisz, J-L. van Laethem, A-S. Boulanger, Geneviève Van Ooteghem, Alexandre Dermine, Sophie Delmarcelle, Nicolas D. Huyghe, Isabelle Bar, Marc Van den Eynde